Acelyrin director Becker sells a single share for compliance reasons By Investing.com
According to a recent filing with the U.S. Securities and Exchange Commission, Daniel J. Baker, director of ACELYRIN, Inc. (NASDAQ:ACLY), sold one share of the company's common stock on July 17, 2024, for $6.86. The transaction was executed…
